Omidenepag Isopropyl Provides Sustained Long-Term IOP Reduction in Glaucoma: Study
A study published in Cureus showed that omidenepag isopropyl achieved significant and sustained reductions in intraocular pressure (IOP) over 5 years in patients with glaucoma. Median IOP remained significantly lower…